PTI

Proteostasis Therapeutics Stock Price

1.11
0.00 (0.0%)
Upgrade to Real-Time
Regular Market
1.11

Low
0.9384

52 Week Range

High
1.94

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Proteostasis Therapeutics Inc PTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.11 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.11
Bid Price Ask Price Spread News
1.12 1.14 0.02 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.11 USD

Period:

Draw Mode:

Proteostasis Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 144.81k 130.46k 2.58M $ 5.00M $ - -23.00 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Proteostasis Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year1.411.940.93841.27699,357-0.30-21.28%
3 Years2.6110.740.613.101,644,264-1.50-57.47%
5 Years10.1320.630.613.731,171,876-9.02-89.04%

Proteostasis Therapeutics Description

Proteostasis Therapeutics Inc is a United States-based clinical-stage biopharmaceutical company committed to the discovery and development of novel therapeutics to treat cystic fibrosis (CF) through theratyping, or the process of matching modulators to individual response to treatment regardless of cystic fibrosis transmembrane conductance regulator (CFTR) mutations. All of the company's revenue is collaboration or license revenue earned from activities in the United States.


Your Recent History
NASDAQ
PTI
Proteostas..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.